China county-based prostate specific antigen screening for prostate cancer and a cost-effective analysis

医学 前列腺癌 前列腺 前列腺癌筛查 癌症 前列腺特异性抗原 肿瘤科 阶段(地层学) 人口 内科学 妇科 生物 环境卫生 古生物学
作者
Zhiguo Zhang,Guoshu Liang,Peng Zhang,Zhongqi Zhao,Zhongnan He,Fengzhen Luo,Zhenqing Chen,Zongke Yang,Zhijie Zhang,Tao Xia,Xin Liu,Yong Zhang,Wei Ye
出处
期刊:Translational Andrology and Urology [AME Publishing Company]
卷期号:10 (10): 3787-3799 被引量:14
标识
DOI:10.21037/tau-21-779
摘要

BACKGROUND: Prostate cancer is one of the most common malignant tumors worldwide, and is the third-leading cause of cancer death in men. Nearly 70% of new prostate cancer patients in China are locally advanced or widely metastatic with poor prognosis. Providing active treatment to early stage prostate cancer patients can improve the prognosis of prostate cancer patients. Thus, this study sought to evaluate the economy of early prostate specific antigen (PSA) screening for high-risk prostate cancer. METHODS: Based on the data collected from the PSA screening activities of 11 county hospitals from October 2019 to April 2021, this study evaluated a high-risk prostate cancer population who received PSA screening and their quality of life and economy. The screening population comprised males aged over 50 years. All screening patients were tested for PSA. If the PSA value is unnormal, a further diagnosis based on magnetic resonance imagining (MRI) or a transrectal ultrasound-guided prostate biopsy were performed. The decision-tree and Markov model was used to simulate the process of disease development of high-risk prostate cancer patients who underwent screenings and those who did not, and the incremental cost-effectiveness ratio was also evaluated. RESULTS: A total of 13,726 men received a PSA screening. Of these, 1,062 men had abnormal PSA values, and 73 of these were diagnosed with prostate cancer. Of these 73 patients, 40, 21, and 12 had early stage, mid-stage, and late-stage prostate cancer, respectively. Compared to the patients unscreened, the 1,000 patients who received an early PSA screening increased their quality-adjusted life year (QALY) by 15.69 years; however, each QALY had an additional cost of 38,550 yuan, which was lower than the willingness to pay threshold of 72,447 yuan (per capita gross domestic product in 2020). CONCLUSIONS: For high-risk prostate cancer patients, early screenings have a cost-effective advantage over no screenings. Thus, early screening should be vigorously promoted for high-risk prostate cancer patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐笑语的应助被科研通管家采纳,获得10
刚刚
寄托完成签到 ,获得积分10
刚刚
乐乐的应助被科研通管家采纳,获得10
刚刚
灿1980s完成签到,获得积分10
刚刚
科目三的应助被科研通管家采纳,获得30
刚刚
刚刚
积极的猎豹完成签到 ,获得积分10
1秒前
HAHAHA完成签到,获得积分10
1秒前
收破烂的要不完成签到,获得积分10
1秒前
嘿嘿完成签到,获得积分10
1秒前
小玫瑰完成签到,获得积分10
1秒前
zgd完成签到,获得积分10
1秒前
ty完成签到 ,获得积分10
3秒前
Ava的应助被Researcher采纳,获得10
3秒前
yoga完成签到,获得积分10
3秒前
笑笑完成签到,获得积分10
3秒前
SG完成签到,获得积分10
4秒前
4秒前
李李玲发布了新的文献求助10
4秒前
专注以筠完成签到,获得积分10
5秒前
煎饼狗子完成签到,获得积分10
5秒前
毛毛完成签到,获得积分10
6秒前
沉睡千年的蛆完成签到,获得积分10
6秒前
sukiii发布了新的文献求助10
6秒前
wl完成签到,获得积分10
6秒前
脆薯饼完成签到,获得积分10
7秒前
丰富的雅绿完成签到,获得积分10
7秒前
勇敢牛牛完成签到,获得积分10
7秒前
caozhi完成签到,获得积分10
8秒前
学习达人完成签到,获得积分10
8秒前
胡彦乱语的咖啡豆完成签到,获得积分10
9秒前
9秒前
阳光的柚子完成签到 ,获得积分10
10秒前
囍囍完成签到,获得积分20
10秒前
aaaddwdf完成签到,获得积分10
10秒前
roselin26完成签到,获得积分10
10秒前
10秒前
Nico_Ding完成签到,获得积分10
11秒前
11秒前
menghan完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173463
求助须知:如何正确求助?哪些是违规求助? 9565690
关于积分的说明 21781315
捐赠科研通 7767647
什么是DOI,文献DOI怎么找? 3431597
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476808